SIBN
SI-BONE, Inc.
Price Chart
Latest Quote
$15.84
+0.63 (+4.14%)
Current Price
| Previous Close | $15.21 |
| Open | $15.45 |
| Day High | $15.93 |
| Day Low | $15.32 |
| Volume | 450,174 |
Stock Information
| Shares Outstanding | 44.35M |
| Total Debt | $42.95M |
| Cash Equivalents | $144.68M |
| Revenue | $206.22M |
| Net Income | $-16.70M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $702.49M |
| EPS (TTM) | $-0.39 |
| Exchange | NGM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $600.76M |
| Sales | $206.22M |
| Income | $-16.70M |
| Book/sh | $4.05 |
| Cash/sh | $3.26 |
| Employees | 376 |
Financial Ratios
| Quick Ratio | 8.20 |
| Current Ratio | 9.99 |
| Debt/Eq | 24.00 |
Returns & Margins
| ROA | -5.30% |
| ROE | -9.64% |
| Gross Margin | 79.59% |
| Operating Margin | -9.69% |
| Profit Margin | -8.10% |
Ownership
| Insider Ownership | 3.42% |
| Institutional Ownership | 108.16% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -44.89 |
| P/S | 3.41 |
| P/B | 3.91 |
Analyst Data
| Recommendation | none |
| Target Price | $24.12 |
Technical Indicators
| SMA20 | $14.85 |
| SMA50 | $14.08 |
| SMA200 | $15.70 |
| RSI | 69.51 |
| ATR | 0.6757 |
| Shares Float | 42.78M |
| Short Float | 15.48% |
| Short Ratio | 6.89 |
| Volatility | 0.70 |
| Rel Volume | 0.98 |
Performance History
| Week | +4.62% |
| Month | +6.74% |
| Quarter | +24.04% |
| 6 Months | -18.43% |
| YTD | -19.96% |
| Year | -7.64% |
| 3 Years | -42.88% |
| 5 Years | -49.54% |
| 10 Years | -21.04% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $15.84 | 469,500 |
| 2026-06-17 | $15.21 | 631,000 |
| 2026-06-16 | $15.41 | 357,300 |
| 2026-06-15 | $15.12 | 649,300 |
| 2026-06-12 | $15.42 | 216,600 |
| 2026-06-11 | $15.14 | 336,900 |
| 2026-06-10 | $15.37 | 356,100 |
| 2026-06-09 | $15.53 | 328,700 |
| 2026-06-08 | $14.97 | 350,700 |
| 2026-06-05 | $15.12 | 378,900 |
| 2026-06-04 | $14.88 | 471,800 |
| 2026-06-03 | $13.92 | 561,400 |
| 2026-06-02 | $14.01 | 480,400 |
| 2026-06-01 | $13.87 | 763,200 |
| 2026-05-29 | $14.10 | 555,400 |
| 2026-05-28 | $14.41 | 507,000 |
| 2026-05-27 | $14.46 | 555,000 |
| 2026-05-26 | $14.67 | 481,200 |
| 2026-05-22 | $14.68 | 324,800 |
| 2026-05-21 | $14.81 | 771,000 |
| 2026-05-20 | $14.82 | 507,000 |
| 2026-05-19 | $14.84 | 582,400 |
About SI-BONE, Inc.
SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.
đ° Latest News
Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now
Zacks âĸ 2026-06-03T13:55:02Z
Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know
Zacks âĸ 2026-06-01T13:55:03Z
How Much Upside is Left in Si-Bone (SIBN)? Wall Street Analysts Think 65.27%
Zacks âĸ 2026-05-15T13:55:02Z
Why Si-Bone Stock Soared by Almost 20% on Tuesday
Motley Fool âĸ 2026-05-12T23:36:49Z
SI-BONE Inc (SIBN) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...
GuruFocus.com âĸ 2026-05-12T07:06:19ZSiBone Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-12T02:14:10Z
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
Zacks âĸ 2026-05-12T00:05:05Z
SI-Bone (SIBN) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-11T22:32:04Z
Jim Cramer on SI-BONE, Inc.: âWeâre Not Going to Buy the Money Losersâ
Insider Monkey âĸ 2026-03-13T15:16:35Z
SI-BONE, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-02-24T13:30:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $41,046,000 | $35,057,000 | $29,466,000 | $15,705,000 |
| Cost Of Revenue | $41,046,000 | $35,057,000 | $29,466,000 | $15,705,000 |
| Total Revenue | $200,925,000 | $167,178,000 | $138,886,000 | $106,409,000 |
| Operating Revenue | $200,925,000 | $167,178,000 | $138,886,000 | $106,409,000 |
| Expenses | ||||
| Interest Expense | $2,628,000 | $3,440,000 | $3,462,000 | $2,819,000 |
| Total Expenses | $223,255,000 | $202,426,000 | $185,817,000 | $166,018,000 |
| Other Income Expense | $-20,000 | $-73,000 | $141,000 | $-132,000 |
| Other Non Operating Income Expenses | $-20,000 | $-73,000 | $141,000 | $-132,000 |
| Net Non Operating Interest Income Expense | $3,446,000 | $4,408,000 | $3,454,000 | $-1,515,000 |
| Interest Expense Non Operating | $2,628,000 | $3,440,000 | $3,462,000 | $2,819,000 |
| Operating Expense | $182,209,000 | $167,369,000 | $156,351,000 | $150,313,000 |
| Selling And Marketing Expense | $124,224,000 | $117,054,000 | $110,254,000 | $107,726,000 |
| General And Administrative Expense | $40,537,000 | $33,755,000 | $31,069,000 | $28,960,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-18,904,000 | $-30,913,000 | $-43,336,000 | $-61,256,000 |
| Net Interest Income | $3,446,000 | $4,408,000 | $3,454,000 | $-1,515,000 |
| Interest Income | $6,074,000 | $7,848,000 | $6,916,000 | $1,304,000 |
| Normalized Income | $-18,904,000 | $-30,913,000 | $-43,336,000 | $-61,256,000 |
| Net Income From Continuing And Discontinued Operation | $-18,904,000 | $-30,913,000 | $-43,336,000 | $-61,256,000 |
| Total Operating Income As Reported | $-22,330,000 | $-35,248,000 | $-46,931,000 | $-59,609,000 |
| Net Income Common Stockholders | $-18,904,000 | $-30,913,000 | $-43,336,000 | $-61,256,000 |
| Net Income | $-18,904,000 | $-30,913,000 | $-43,336,000 | $-61,256,000 |
| Net Income Including Noncontrolling Interests | $-18,904,000 | $-30,913,000 | $-43,336,000 | $-61,256,000 |
| Net Income Continuous Operations | $-18,904,000 | $-30,913,000 | $-43,336,000 | $-61,256,000 |
| Pretax Income | $-18,904,000 | $-30,913,000 | $-43,336,000 | $-61,256,000 |
| Interest Income Non Operating | $6,074,000 | $7,848,000 | $6,916,000 | $1,304,000 |
| Operating Income | $-22,330,000 | $-35,248,000 | $-46,931,000 | $-59,609,000 |
| Gross Profit | $159,879,000 | $132,121,000 | $109,420,000 | $90,704,000 |
| Per Share | ||||
| Diluted EPS | $-0.44 | $-0.75 | $-1.13 | $-1.79 |
| Basic EPS | $-0.44 | $-0.75 | $-1.13 | $-1.79 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-10,506,000 | $-23,094,000 | $-34,446,000 | $-54,985,000 |
| Reconciled Depreciation | $5,770,000 | $4,379,000 | $5,428,000 | $3,452,000 |
| EBITDA (Bullshit earnings) | $-10,506,000 | $-23,094,000 | $-34,446,000 | $-54,985,000 |
| EBIT | $-16,276,000 | $-27,473,000 | $-39,874,000 | $-58,437,000 |
| Diluted Average Shares | $42,959,856 | $41,466,564 | $38,427,419 | $34,201,824 |
| Basic Average Shares | $42,959,856 | $41,466,564 | $38,427,419 | $34,201,824 |
| Diluted NI Availto Com Stockholders | $-18,904,000 | $-30,913,000 | $-43,336,000 | $-61,256,000 |
| Research And Development | $17,448,000 | $16,560,000 | $15,028,000 | $13,627,000 |
| Selling General And Administration | $164,761,000 | $150,809,000 | $141,323,000 | $136,686,000 |
| Other Gand A | $40,537,000 | $33,755,000 | $31,069,000 | $28,960,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $177,532,000 | $166,964,000 | $169,375,000 | $98,302,000 |
| Total Assets | $238,555,000 | $230,437,000 | $230,425,000 | $157,552,000 |
| Total Non Current Assets | $22,440,000 | $22,658,000 | $19,031,000 | $19,941,000 |
| Other Non Current Assets | $55,000 | $300,000 | $325,000 | $375,000 |
| Current Assets | $216,115,000 | $207,779,000 | $211,394,000 | $137,611,000 |
| Other Current Assets | $4,480,000 | $3,204,000 | $3,173,000 | $2,365,000 |
| Inventory | $33,897,000 | $27,074,000 | $20,249,000 | $17,282,000 |
| Receivables | $29,915,000 | $27,459,000 | $21,953,000 | $20,674,000 |
| Accounts Receivable | $29,915,000 | $27,459,000 | $21,953,000 | $20,674,000 |
| Allowance For Doubtful Accounts Receivable | $-1,013,000 | $-588,000 | $-1,118,000 | $-400,000 |
| Gross Accounts Receivable | $30,928,000 | $28,047,000 | $23,071,000 | $21,074,000 |
| Cash Cash Equivalents And Short Term Investments | $147,823,000 | $150,042,000 | $166,019,000 | $97,290,000 |
| Cash And Cash Equivalents | $42,240,000 | $34,948,000 | $33,271,000 | $20,717,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $36,688,000 | $37,483,000 | $38,992,000 | $39,430,000 |
| Long Term Debt And Capital Lease Obligation | $35,744,000 | $36,331,000 | $37,576,000 | $38,042,000 |
| Long Term Debt | $35,569,000 | $35,452,000 | $36,065,000 | $35,171,000 |
| Current Debt And Capital Lease Obligation | $944,000 | $1,152,000 | $1,416,000 | $1,388,000 |
| Net Debt | - | $504,000 | $2,794,000 | $14,454,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $61,023,000 | $63,473,000 | $61,050,000 | $59,250,000 |
| Total Non Current Liabilities Net Minority Interest | $35,744,000 | $36,341,000 | $37,594,000 | $38,072,000 |
| Current Liabilities | $25,279,000 | $27,132,000 | $23,456,000 | $21,178,000 |
| Other Current Liabilities | $879,000 | $938,000 | $1,012,000 | $973,000 |
| Payables And Accrued Expenses | $9,554,000 | $11,128,000 | $7,564,000 | $7,452,000 |
| Payables | $4,631,000 | $6,488,000 | $4,588,000 | $6,279,000 |
| Accounts Payable | $4,631,000 | $6,488,000 | $4,588,000 | $6,279,000 |
| Other Non Current Liabilities | - | $10,000 | $18,000 | $30,000 |
| Equity | ||||
| Common Stock Equity | $177,532,000 | $166,964,000 | $169,375,000 | $98,302,000 |
| Total Equity Gross Minority Interest | $177,532,000 | $166,964,000 | $169,375,000 | $98,302,000 |
| Stockholders Equity | $177,532,000 | $166,964,000 | $169,375,000 | $98,302,000 |
| Gains Losses Not Affecting Retained Earnings | $816,000 | $244,000 | $335,000 | $232,000 |
| Retained Earnings | $-450,258,000 | $-431,354,000 | $-400,441,000 | $-357,105,000 |
| Other | ||||
| Ordinary Shares Number | $43,647,131 | $42,086,477 | $40,693,299 | $34,731,577 |
| Share Issued | $43,647,131 | $42,086,477 | $40,693,299 | $34,731,577 |
| Tangible Book Value | $177,532,000 | $166,964,000 | $169,375,000 | $98,302,000 |
| Invested Capital | $213,101,000 | $202,416,000 | $205,440,000 | $133,473,000 |
| Working Capital | $190,836,000 | $180,647,000 | $187,938,000 | $116,433,000 |
| Capital Lease Obligations | $1,119,000 | $2,031,000 | $2,927,000 | $4,259,000 |
| Total Capitalization | $213,101,000 | $202,416,000 | $205,440,000 | $133,473,000 |
| Additional Paid In Capital | $626,970,000 | $598,070,000 | $569,477,000 | $455,172,000 |
| Capital Stock | $4,000 | $4,000 | $4,000 | $3,000 |
| Common Stock | $4,000 | $4,000 | $4,000 | $3,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $175,000 | $879,000 | $1,511,000 | $2,871,000 |
| Current Capital Lease Obligation | $944,000 | $1,152,000 | $1,416,000 | $1,388,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $13,902,000 | $13,914,000 | $13,464,000 | $11,365,000 |
| Current Accrued Expenses | $4,923,000 | $4,640,000 | $2,976,000 | $1,173,000 |
| Net PPE | $22,385,000 | $22,358,000 | $18,706,000 | $19,566,000 |
| Accumulated Depreciation | $-22,547,000 | $-19,541,000 | $-15,246,000 | $-10,207,000 |
| Gross PPE | $44,932,000 | $41,899,000 | $33,952,000 | $29,773,000 |
| Leases | $3,873,000 | $3,873,000 | $3,873,000 | $1,631,000 |
| Construction In Progress | $5,901,000 | $6,212,000 | $3,856,000 | $7,854,000 |
| Other Properties | $26,820,000 | $25,142,000 | $20,911,000 | $17,094,000 |
| Machinery Furniture Equipment | $8,338,000 | $6,672,000 | $5,312,000 | $3,194,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Inventories | $-3,000 | $-26,000 | $49,000 | $-18,000 |
| Finished Goods | $29,900,000 | $24,000,000 | $18,800,000 | $15,600,000 |
| Work In Process | $4,000,000 | $3,100,000 | $1,400,000 | $1,700,000 |
| Other Short Term Investments | $105,583,000 | $115,094,000 | $132,748,000 | $76,573,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-9,089,000 | $-22,922,000 | $-26,512,000 | $-51,162,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-675,000 | $-12,425,000 | $-18,713,000 | $-41,655,000 |
| Cash Flow From Continuing Operating Activities | $-675,000 | $-12,425,000 | $-18,713,000 | $-41,655,000 |
| Operating Gains Losses | $1,627,000 | $1,877,000 | $1,302,000 | $153,000 |
| Investing Activities | ||||
| Capital Expenditure | $-8,414,000 | $-10,497,000 | $-7,799,000 | $-9,507,000 |
| Investing Cash Flow | $4,160,000 | $12,623,000 | $-59,798,000 | $-2,815,000 |
| Cash Flow From Continuing Investing Activities | $4,160,000 | $12,623,000 | $-59,798,000 | $-2,815,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $0 | $83,671,000 | $0 |
| Financing Cash Flow | $3,376,000 | $1,958,000 | $90,933,000 | $2,197,000 |
| Cash Flow From Continuing Financing Activities | $3,376,000 | $1,958,000 | $90,933,000 | $2,197,000 |
| Net Common Stock Issuance | $0 | $0 | $83,671,000 | $0 |
| Common Stock Issuance | $0 | $0 | $83,671,000 | $0 |
| Net Other Financing Charges | - | $-720,000 | $-40,000 | - |
| Other | ||||
| Repayment Of Debt | $0 | $-36,000,000 | $-35,275,000 | $0 |
| Issuance Of Debt | $0 | $35,954,000 | $35,960,000 | $0 |
| Interest Paid Supplemental Data | $2,533,000 | $3,346,000 | $3,263,000 | $2,621,000 |
| End Cash Position | $42,240,000 | $34,948,000 | $33,271,000 | $20,717,000 |
| Beginning Cash Position | $34,948,000 | $33,271,000 | $20,717,000 | $63,419,000 |
| Effect Of Exchange Rate Changes | $431,000 | $-479,000 | $132,000 | $-429,000 |
| Changes In Cash | $6,861,000 | $2,156,000 | $12,422,000 | $-42,273,000 |
| Proceeds From Stock Option Exercised | $3,376,000 | $2,724,000 | $6,577,000 | $2,197,000 |
| Net Issuance Payments Of Debt | $0 | $-46,000 | $685,000 | $0 |
| Net Long Term Debt Issuance | $0 | $-46,000 | $685,000 | $0 |
| Long Term Debt Payments | $0 | $-36,000,000 | $-35,275,000 | $0 |
| Long Term Debt Issuance | $0 | $35,954,000 | $35,960,000 | $0 |
| Net Investment Purchase And Sale | $12,574,000 | $23,120,000 | $-51,999,000 | $6,692,000 |
| Sale Of Investment | $205,100,000 | $228,500,000 | $137,500,000 | $126,200,000 |
| Purchase Of Investment | $-192,526,000 | $-205,380,000 | $-189,499,000 | $-119,508,000 |
| Net PPE Purchase And Sale | $-8,414,000 | $-10,497,000 | $-7,799,000 | $-9,507,000 |
| Purchase Of PPE | $-8,414,000 | $-10,497,000 | $-7,799,000 | $-9,507,000 |
| Change In Working Capital | $-14,325,000 | $-10,120,000 | $-4,833,000 | $-7,961,000 |
| Change In Payables And Accrued Expense | $-1,584,000 | $3,769,000 | $2,770,000 | $3,736,000 |
| Change In Accrued Expense | $179,000 | $1,908,000 | $3,888,000 | $1,207,000 |
| Change In Payable | $-1,763,000 | $1,861,000 | $-1,118,000 | $2,529,000 |
| Change In Account Payable | $-1,763,000 | $1,861,000 | $-1,118,000 | $2,529,000 |
| Change In Prepaid Assets | $-1,030,000 | $-2,000 | $-762,000 | $810,000 |
| Change In Inventory | $-8,684,000 | $-8,047,000 | $-4,719,000 | $-6,028,000 |
| Change In Receivables | $-3,027,000 | $-5,840,000 | $-2,122,000 | $-6,479,000 |
| Changes In Account Receivables | $-3,027,000 | $-5,840,000 | $-2,122,000 | $-6,479,000 |
| Other Non Cash Items | $687,000 | $623,000 | $969,000 | $348,000 |
| Stock Based Compensation | $25,524,000 | $25,869,000 | $24,057,000 | $23,061,000 |
| Provisionand Write Offof Assets | $1,997,000 | $1,300,000 | $1,709,000 | $319,000 |
| Amortization Of Securities | $-3,051,000 | $-5,440,000 | $-4,009,000 | $229,000 |
| Depreciation Amortization Depletion | $5,770,000 | $4,379,000 | $5,428,000 | $3,452,000 |
| Depreciation And Amortization | $5,770,000 | $4,379,000 | $5,428,000 | $3,452,000 |
| Depreciation | $5,800,000 | - | - | - |
| Gain Loss On Sale Of PPE | $1,627,000 | $1,877,000 | $1,302,000 | $153,000 |
| Net Income From Continuing Operations | $-18,904,000 | $-30,913,000 | $-43,336,000 | $-61,256,000 |
| Asset Impairment Charge | - | - | - | - |
Fetched: 2026-06-18